MNDY Insider Plans Sale of 6,249 Shares Worth $1.9M (Form 144)
monday.com Ltd. (MNDY) – Form 144 filing The notice discloses that shareholder Aviad Eyal intends to sell 6,249 common shares of monday.com through Goldman Sachs & Co. LLC on or about 07 July 2025.
Rhea-AI Filing Summary
monday.com Ltd. (MNDY) – Form 144 filing
The notice discloses that shareholder Aviad Eyal intends to sell 6,249 common shares of monday.com through Goldman Sachs & Co. LLC on or about 07 July 2025. At the most recent market price used in the filing, the proposed sale is valued at $1.91 million. The company has 50,773,337 shares outstanding, so the planned disposition represents roughly 0.012 % of outstanding stock.
During the last three months, the same seller reported three prior transactions totaling 6,253 shares for gross proceeds of $1.69 million. When aggregated with the planned sale, the 90-day total reaches 12,502 shares (about 0.025 % of shares outstanding), remaining well below the 1 % and volume thresholds typically used to assess Rule 144 activity.
No purchase-price debt, gifts, or special payment arrangements are disclosed. The filer certifies no undisclosed material adverse information and indicates compliance with Rule 10b5-1 if applicable.
Investment view: The notice signals limited insider selling. The share count and value are small relative to the company’s float and are unlikely to exert meaningful market pressure absent additional sales.
Positive
- None.
Negative
- Insider selling: Filer plans to dispose of 6,249 shares worth $1.9 million, adding to 12,500 shares sold in the last 90 days.
Insights
TL;DR: Minor insider sale (0.012 % of shares) – likely negligible market impact.
The filing reveals a small Rule 144 sale by Aviad Eyal. Even when combined with prior 90-day sales, total volume is <0.03 % of outstanding shares—far below the 1 % cap and average-day-trading-volume limits. The $1.9 million value is immaterial for a multi-billion-dollar company. Such transactions are routine for liquidity or diversification and do not imply operational weakness. I view the disclosure as neutral; price effect should be minimal barring larger follow-on sales.
TL;DR: Routine compliance filing; no red flags in governance terms.
The seller provided full acquisition details, affirmed no undisclosed adverse information, and listed past sales, demonstrating adherence to Rule 144 and 10b5-1 requirements. Absence of complex consideration or related-party payments reduces governance risk. From a stewardship lens, the sale size is too small to question commitment or signal strategic shift. Impact on shareholder interests is therefore negligible.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is the seller named in the Form 144 filing?
What broker will execute the sale?
How do recent insider sales compare to this planned sale?
Does the filing indicate any undisclosed adverse information?
AI-generated analysis. How Rhea-AI works. Not financial advice.